ere’s what we’re looking out for this week in the worlds of pharma and biotech:

Still waiting on that fantastic FDA pick

This may yet be the week that President Trump unveils the new FDA commissioner. If you trust the pollsters, former FDA deputy commissioner Dr. Scott Gottlieb is emerging as the biopharma community’s top choice. Whoever Trump’s so-called fantastic pick is, we can bet that he or she will veer in the direction of deregulation.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.